EM.P.1.02 Long-term activin receptor type IIB inhibition improves strength and function of dystrophic muscle
Year: 2009
Type: article
Source: Neuromuscular Disorders
Institutions: Acceleron Pharma (United States), University of Pennsylvania
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1994788076
